(Press-News.org) The number of drugs covered by public drug plans decreased substantially after Canada's Common Drug Review was introduced in 2003, and new drugs were listed more quickly in several of the smaller provinces, found a study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/site/embargo/cmaj110670.pdf.
Canada has 19 public drug plans, which accounted for about 39% of the forecasted $31 billion in drug-related costs in 2010. These plans cover the cost of a range of drugs prescribed to patients. Before 2003, each plan independently reviewed evidence for clinical and cost-effectiveness for new drugs under consideration for listing under drug plans. The Canada Common Drug Review, administered by the Canadian Agency for Drugs and Technologies in Health, was introduced to standardize the process, improve efficiencies by pooling resources and expertise and eliminate duplication. Quebec does not participate in the Common Drug Review.
Researchers from the University of Alberta found that the number of drugs listed for coverage decreased substantially. Participating drug plans listed between 47% and 66% of new drugs in the five years before the Common Drug Review and between 12% and 40% in the five years following. As well, the time from recommendation to be listed and actual date listed ranged from 99 to 358 days, compared with an average time-to-listing of 778 days — more than two years — before the Common Drug Review.
There was also significant variation between listing decisions of public drug plans and recommendations of the Common Drug Review.
"The proportion of drugs listed decreased significantly after the introduction of the Common Drug Review for all participating drug plans included in our analysis," states Dr. Dean Eurich, School of Public Health, University of Alberta, with coauthors. "Time-to-listing decreased for a number of the smaller provinces."
The authors write that several factors, including uncertainty over the clinical effectiveness of drugs submitted by pharmaceutical companies for review, may explain the decrease in the number of drugs listed for reimbursement.
"Our findings suggest that the Common Drug Review may have contributed to a streamlining of the process for reviewing drugs for certain jurisdictions," write the authors "Specifically, patients in the provinces of New Brunswick, Prince Edward Island, and Newfoundland and Labrador may have benefited with earlier access to new drugs. Any substantial gains in savings or in the efficiency of publicly funded drug plans to make listing decisions are important factors in maintaining the health and safety of Canadian patients."
### END
Impact of Canada's Common Drug Review on drug listing
2011-10-25
ELSE PRESS RELEASES FROM THIS DATE:
Statewide Solutions NJ Now Certified in Mold Remediation
2011-10-25
Statewide Solutions NJ is proud to announce that they are now certified in Mold Remediation by NORMI; the National Organization of Remediators and Mold Inspectors.
The certification is earned by taking part in rigorous training and passing a certification exam to ensure thorough understanding of EPA and industry standard protocols for mold assessment and remediation. Some of the information covered during training includes microbial remediation standards, mold equipment calibration and operation, safety procedures, contact with regulated substances, preventing cross ...
Consumers don't pay as much attention to nutrition fact labels as they think
2011-10-25
Philadelphia, PA, October 24, 2011 – Nutrition Facts labels have been used for decades on many food products. Are these labels read in detail by consumers when making purchases? Do people read only certain portions of the labels? According to a new study published in the November issue of the Journal of the American Dietetic Association, consumers' self-reported viewing of Nutrition Facts label components was higher than objectively measured viewing using an eye-tracking device. Researchers also determined that centrally located Nutrition Facts labels are viewed more frequently ...
Exposure to chemical BPA before birth linked to behavioral, emotional difficulties in girls
2011-10-25
Boston, MA – Exposure in the womb to bisphenol A (BPA) – a chemical used to make plastic containers and other consumer goods – is associated with behavior and emotional problems in young girls, according to a study led by researchers at Harvard School of Public Health (HSPH), Cincinnati Children's Hospital and Medical Center, and Simon Fraser University in Vancouver, British Columbia.
BPA is found in many consumer products, including canned food linings, polycarbonate plastics, dental sealants, and some receipts made from thermal paper. Most people living in industrialized ...
More time outdoors may reduce kids' risk for nearsightedness
2011-10-25
ORLANDO, Fla. –October 24, 2011– A new analysis of recent eye health studies shows that more time spent outdoors is related to reduced rates of nearsightedness, also known as myopia, in children and adolescents. Myopia is much more common today in the United States and many other countries than it was in the 1970s. In parts of Asia, more than 80 percent of the population is nearsighted. The analysis suggests that more exposure to natural light and/or time spent looking at distant objects may be key factors. Today at the 115th Annual Meeting of the American Academy of Ophthalmology ...
Vitamin B-based treatment for corneal disease may offer some patients a permanent solution
2011-10-25
ORLANDO, Fla. – October 24, 2011 – Patients in the United States who have the cornea-damaging disease keratoconus may soon be able to benefit from a new treatment that is already proving effective in Europe and other parts of the world. The treatment, called collagen crosslinking, improved vision in almost 70 percent of patients treated for keratoconus in a recent three-year clinical trial in Milan, Italy. The treatment is in clinical trials in the United States and is likely to receive FDA approval in 2012. The results of the Milan study are being presented today at the ...
AFP Brandywine Chapter Announces Annual Philanthropy Day Winners
2011-10-25
Brandywine Chapter of the Association of Fundraising Professionals (AFP) is pleased to announce the winners of the 2011 Philanthropy Day Awards: Sonia Schorr Sloan, Jane Wilkie, Barclay's Bank and Matthew Ryan McNeill. The winners will be honored on Wednesday, November 16th during the Chapter's annual Philanthropy Day activities being held at Deerfield Golf and Tennis Club.
Sonia Schorr Sloan of Brandywine Hundred is receiving the Professional Life-Time Achievement Award for decades of service to numerous organizations. Sonia was instrumental in the founding of a number ...
Surprises of the measles virus structure
2011-10-25
Professor Sarah Butcher's research group from Helsinki University's Institute of Biotechnology report in the 24th October online issue of the journal Proceedings of the National Academy of Sciences (U.S.A.) a three-dimensional model of measles virus. The new model helps to explain many previous, unaccounted for observations in the life cycle of the virus.
Measles is an important disease worldwide that is highly infectious, causing the deaths of over 100000 people annually. According to the latest figures from the World Health Organisation, 33 countries in Europe have ...
Study hints at possible therapeutic strategy to combat premature birth
2011-10-25
CINCINNATI – Scientists who developed a novel mouse model mimicking human preterm labor have described a molecular signaling pathway underlying preterm birth and targeted it to stop the problem.
In a study to be published online the week of Oct. 24 by PNAS (Proceedings of the National Academy of Sciences), the researchers report their findings may lead to new strategies for combating this major global health issue in humans. The study was led by scientists in the division of Reproductive Sciences and Perinatal Institute at Cincinnati Children's Hospital Medical Center.
They ...
Mayo Clinic detective work shows possible side effect in macular degeneration drug
2011-10-25
ROCHESTER, Minn. -- Two major drug trials conclude there was little risk from a drug aimed at age-related macular degeneration. Yet a Mayo Clinic ophthalmologist began to note something concerning in some of her patients: an increase in pressure inside the eye. It led to a retrospective study and findings that will be presented at the American Academy of Ophthalmology in Orlando.
Sophie Bakri, M.D., had been treating patients in her clinic with Food and Drug Administration-approved ranibizumab (Lucentis), when she began noticing a change in some patients.
"I was treating ...
Morning UV exposure may be less damaging to the skin
2011-10-25
(Embargoed) CHAPEL HILL – Research from the University of North Carolina at Chapel Hill suggests that the timing of exposure to UV rays – early in the morning or later in the afternoon – can influence the onset of skin cancer.
The study, performed in mice, found that exposure to UV radiation in the morning increased the risk of skin cancer by 500 percent over identical doses in the afternoon. Although mice and humans both reside on a 24-hour day, the "circadian" clocks of these nocturnal and diurnal creatures run counter each other. This key difference in biology means ...